WO2003106635A9 - Functional sites - Google Patents

Functional sites Download PDF

Info

Publication number
WO2003106635A9
WO2003106635A9 PCT/US2003/018714 US0318714W WO03106635A9 WO 2003106635 A9 WO2003106635 A9 WO 2003106635A9 US 0318714 W US0318714 W US 0318714W WO 03106635 A9 WO03106635 A9 WO 03106635A9
Authority
WO
WIPO (PCT)
Prior art keywords
functional sites
sites
functional
Prior art date
Application number
PCT/US2003/018714
Other languages
French (fr)
Other versions
WO2003106635A2 (en
Inventor
John A. Stamatoyannopoulos
Michael Mcarthur
Peter J. Sabo
Original Assignee
Regulome Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US38788702P priority Critical
Priority to US38791002P priority
Priority to US60/387,910 priority
Priority to US60/387,887 priority
Application filed by Regulome Corporation filed Critical Regulome Corporation
Publication of WO2003106635A2 publication Critical patent/WO2003106635A2/en
Publication of WO2003106635A9 publication Critical patent/WO2003106635A9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
PCT/US2003/018714 2002-06-13 2003-06-13 Functional sites WO2003106635A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US38788702P true 2002-06-13 2002-06-13
US38791002P true 2002-06-13 2002-06-13
US60/387,910 2002-06-13
US60/387,887 2002-06-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003245488A AU2003245488A1 (en) 2002-06-13 2003-06-13 Functional sites

Publications (2)

Publication Number Publication Date
WO2003106635A2 WO2003106635A2 (en) 2003-12-24
WO2003106635A9 true WO2003106635A9 (en) 2010-01-21

Family

ID=29739965

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2003/018714 WO2003106635A2 (en) 2002-06-13 2003-06-13 Functional sites
PCT/IB2003/004491 WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/004491 WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Country Status (2)

Country Link
AU (2) AU2003276494A1 (en)
WO (2) WO2003106635A2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US20040019915A1 (en) 2002-04-01 2004-01-29 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
EP1578399A4 (en) 2002-12-06 2007-11-28 Isis Pharmaceuticals Inc Methods for rapid identification of pathogens in humans and animals
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
CA2567839C (en) 2004-05-24 2011-06-28 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
ES2394969T3 (en) * 2004-12-30 2013-02-07 Vito Michele Fazio Immunogenic anti-tumor peptides and vaccine containing them
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
EP1869180B1 (en) 2005-03-03 2013-02-20 Ibis Biosciences, Inc. Compositions for use in identification of polyoma viruses
WO2007014045A2 (en) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CN101466836A (en) 2006-04-11 2009-06-24 卫材R&D管理有限公司 Dopaminergic neuron progenitor cell marker 187A5
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
JP5680304B2 (en) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド Rapid forensic DNA analysis
WO2008113773A2 (en) * 2007-03-16 2008-09-25 Biorigen S.R.L. Gene expression regulation technology and noncoding rnas for diagnosis and therapy
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
JP5301652B2 (en) 2008-07-25 2013-09-25 インフォコム株式会社 New oncogene NRF2
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
CA2742531A1 (en) * 2008-11-04 2010-05-14 Idera Pharmaceuticals, Inc. Modulation of toll-like receptor 5 expression by antisense oligonucleotides
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc Ionization probe assemblies
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
ES2628739T3 (en) 2009-10-15 2017-08-03 Ibis Biosciences, Inc. Multiple displacement amplification
EP3409287A1 (en) 2010-09-29 2018-12-05 Agensys, Inc. Antibody drug conjugates (adc) that bind to 191p4d12 proteins
JP6090937B2 (en) 2011-07-27 2017-03-08 国立大学法人京都大学 Novel dopaminergic neural progenitor cell marker
WO2015024017A2 (en) * 2013-08-16 2015-02-19 President And Fellows Of Harvard College Rna polymerase, methods of purification and methods of use
MX2017002900A (en) * 2014-09-04 2017-10-24 Memorial Sloan-Kettering Cancer Center Global gene therapy for treating hemoglobinopathies.
US10450572B2 (en) * 2016-08-12 2019-10-22 Regents Of The University Of Minnesota Androgen receptor variant inhibitors and methods of using

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1330543A4 (en) * 2000-10-02 2006-03-29 Bayer Ag Nucleic acid sequences differentially expressed in cancer tissue

Also Published As

Publication number Publication date
AU2003276494A1 (en) 2004-01-23
AU2003276494A8 (en) 2004-01-23
WO2003106635A2 (en) 2003-12-24
AU2003245488A1 (en) 2003-12-31
WO2004005458A2 (en) 2004-01-15
AU2003245488A8 (en) 2010-02-11
WO2004005458A3 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
AU2003226592A1 (en) Antenna arrangement
AU2003244672A1 (en) Positioning technique
AU2003236906A1 (en) Catalyst
AU2002343987A1 (en) Steering device
AU2003265509A1 (en) Neurostimulator
AU2003216002A1 (en) Efficient mmicrofluidic devices
AU2003216004A1 (en) Multimodulation transmitter
AU2003206527A1 (en) Attachment device
AU2003276458A1 (en) 2-oxo-ethanesulfonamide derivates
AU2002359884A1 (en) An improved control - hold mode
AU2003266949A1 (en) Compounds
AU2003217296A1 (en) Grouser
AU2003262722A1 (en) Subwoofer
AU2002352768A1 (en) Multifunctional world-wide-walkie-talkie
AU2003289047A1 (en) Needle-insertion device
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003237647A1 (en) Lid-positioning device
AU2003281272A1 (en) Fireblocking device
AU2003233465A1 (en) Structural member
AU2003239909A1 (en) Enhanced-service provision
AU2003276494A8 (en) Functional sites
AU2003243226A1 (en) Vitamin-mitomycin conjugates
AU2003279369A1 (en) Device
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase
WWW Wipo information: withdrawn in national office

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: JP